Records containing: Lymphoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2023-08-08Effectiveness of Integrative Medicine Treatments in Lymphoma Survivors
-
CLINICAL_TRIALS study record update · 2023-08-04A Phase I Study of AT7519M Given Twice Weekly in Patients With Advanced Incurable Malignancy
-
CLINICAL_TRIALS study record update · 2023-08-04A Phase II Study of Bortezomib and Gemcitabine in Patients With Relapsed Mantle Cell Lymphoma
-
CLINICAL_TRIALS study record update · 2023-08-04A Phase II Study Of PS-341 (NSC 681239) In Patients With Untreated Or Relapsed Mantle Cell Lymphoma
-
CLINICAL_TRIALS study record update · 2023-08-02A Phase I, Open-Label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of Ascending Doses of AZD0466 in Patients With Advanced Hematologic or Solid Tumors
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2023-08-01The Role of Sonoelastography in Evaluation of Therapeutic Response in Patients With Lymphoma.
-
CLINICAL_TRIALS study record update · 2023-07-18A Phase 1, Multicenter, Open-label Study of BMS-986403 in Subjects With Relapsed and/or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
-
CLINICAL_TRIALS study record update · 2023-07-17The Effectiveness of Lactobacillus Plantarum (LBP, IND# 17339) in Preventing Acute Graft-Versus-Host Disease (GvHD) in Children Undergoing Alternative Hematopoietic Progenitor Cell Transplantation (HCT)
-
CLINICAL_TRIALS study record update · 2023-07-17Phase I/II Study of CD70 Targeted CAR-T Cell Treatment in CD70 Positive Relapsed/Refractory Lymphoma
-
CLINICAL_TRIALS study record update · 2023-07-11A Pilot Study Using FDG-PET/CT Imaging as an Early Predictor of Disease Response in Lymphoma Subjects Receiving Redirected Autologous CART- 19 T-cell Immunotherapy
-
CLINICAL_TRIALS study record update · 2023-06-28Safety and Efficacy Study of KL-7SHRNA Injection Solution in the Treatment of AIDS Patients With Lymphoma
-
CLINICAL_TRIALS study record update · 2023-06-27Rituximab Plus Lenalidomide or Rituximab Monotherapy for Untreated Patients With Follicular Lymphoma in Need of Therapy. A Randomized, Open-Label, Multicenter Phase II Trial.
-
CLINICAL_TRIALS study record update · 2023-06-22A Phase II Study of Doxil (Liposomal Doxorubicin), Cyclophosphamide, Vincristine and Prednisone for AIDS-Related Systemic Lymphoma
-
CLINICAL_TRIALS study record update · 2023-06-22Ancillary Laboratory Protocol For the Collection of Diagnostic Material On Patients Considered For ECOG Treatment Trials For Leukemia Or Related Hematologic Disorders
-
CLINICAL_TRIALS study record update · 2023-06-18Follow-up for Patients Previously Enrolled on the Center for Cancer Research Protocols
-
CLINICAL_TRIALS study record update · 2023-06-18A Retrospective Study on Extranodal Lymphoma or Lymphoma of Rare Pathological Types
-
CLINICAL_TRIALS study record update · 2023-06-15A Phase II Study of DAB 389 IL-2, an Interleukin-2 Fusion Toxin, for Previously Treated Stage II, III, and IV Follicular Low-Grade Non-Hodgkin's Lymphoma
-
CLINICAL_TRIALS study record update · 2023-06-15Brief Physician-Initiated Quit Smoking Strategies for Clinical Oncology Settings
-
CLINICAL_TRIALS study record update · 2023-06-15An Open-Label Phase 1/2 Study of Itacitinib (INCB039110) in Combination With Ibrutinib in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
-
CLINICAL_TRIALS study record update · 2023-06-09An Open-Label, Multicenter, Dose-Escalation and Expansion Phase Ia/Ib Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of KN046 Monotherapy in Subjects With Advanced Solid Tumors and Lymphoma
-
CLINICAL_TRIALS study record update · 2023-06-09A Geriatric Assessment Intervention for Patients Aged 70 and Over Receiving Chemotherapy or Similar Agents for Advanced Cancer: Reducing Toxicity in Older Adults
-
CLINICAL_TRIALS study record update · 2023-06-07Strategy Therapy on Early Phase Cancer Therapeutics-Related Cardiac Dysfunction Patients
-
CLINICAL_TRIALS study record update · 2023-06-05An Open-label Study of ALPN-202 in Subjects With Advanced Malignancies (NEON-1)
-
CLINICAL_TRIALS study record update · 2023-05-30A Phase 1, Open-Label, Multicenter Trial Investigating the Safety, Tolerability, and Preliminary Antineoplastic Activity of Sym021 (Anti-PD-1) as Monotherapy, in Combination With Either Sym022 (Anti-LAG-3) or Sym023 (Anti-TIM-3), and in Combination With Both Sym022 and Sym023 in Patients With Advanced Solid Tumor Malignancies or Lymphomas
-
CLINICAL_TRIALS study record update · 2023-05-24AuTophagy Activation for Cardiomyopathy Due to Anthracycline tReatment (ATACAR) Trial